Although some progress has been made in the last 3 decades to increase the number of
women in clinical cardiology trials, review of recent cardiovascular literature demonstrates …

In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …

Objective To determine vaccine acceptance and hesitancy attitudes toward coronavirus
disease 2019 (COVID‐19) vaccines in pregnant women. Methods Three hundred pregnant …

Pregnant and lactating women (PLW) represent a particular population subset with
increased susceptibility for COVID-19 morbidity and mortality, even though the evidence …

Pregnant womenwith severe or critical coronavirus disease 2019 (COVID-19) infection are
at increased risk for preterm birth and pregnancy loss. In studies of hospitalized pregnant …

As of December 1, 2020, nearly 64 million people have been infected with the severe acute
respiratory syndrome coronavirus 2 worldwide with nearly 1.5 million global deaths. The …

The pandemic caused by COVID‐19 is affecting populations and healthcare systems
worldwide. As we gain experience managing COVID‐19, more data become available on …

Infectious diseases can directly affect women and men differently. During the COVID‐19
pandemic, higher case fatality rates have been observed in men in most countries. There is …

BACKGROUND: Studies evaluating the safety and efficacy of currently available vaccines
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not include pregnant …

The development of SARS-CoV-2 vaccines represents a significant breakthrough for
managing the COVID-19 pandemic. However, their approval process has exposed a crucial …